Zofenopril Calcium丨CAS 81938-43-4

Zofenopril Calcium丨CAS 81938-43-4
Product Introduction:
Catalog No.: SS127407
CAS No.: 81938-43-4
Purity: 98% min
Product Name: Zofenopril calcium
Molecular Formula: 2(C22H22NO4S2).Ca
Molecular Weight: 897.17
Synonym(s): Zoprace
Send Inquiry
Technical Parameters
Description

Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of zofenopril calcium丨cas 81938-43-4 in China. Welcome to wholesale bulk high quality chemical products at competitive price from our factory. If you have any enquiry about custom service, please feel free to email us.

 

Specifications

 

Appearance:

White to off-white solid

Purity:

98% min

Specific rotation:

D23 -67.6° (c = 1 in methanol/HCl)

Solubility:

Dimethyl sulfoxide: 5 mg/mL min

 

Transport Information

 

Parameter

Specification

UN Number

3077

Class

9

Packing Group

III

H.S. Code

2932209090303

Stability & Reactivity

The product is chemically stable under standard ambient conditions.

Storage

Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

Condition to Avoid

 

Package

 

 

 

 

Overview

Zofenopril calcium丨CAS 81938-43-4 is a prescription cardiovascular drug used primarily for treating hypertension and post-myocardial infarction (MI). It belongs to the ACE inhibitor class, working by inhibiting the enzyme responsible for the conversion of angiotensin I to angiotensin II-a powerful vasoconstrictor.


 

Applications

1. Treatment of Hypertension

Zofenopril calcium丨CAS 81938-43-4 is used to lower elevated blood pressure by:

Reducing angiotensin II levels

Promoting vasodilation

Decreasing aldosterone secretion

2. Management of Heart Failure

Improves cardiac function in patients with chronic heart failure, especially when used with diuretics or beta-blockers.

Reduces preload and afterload, easing strain on the heart.

3. Post-Myocardial Infarction Therapy

Proven efficacy in reducing mortality and preventing reinfarction in patients recovering from an acute MI, particularly when started early.

Offers cardioprotective effects via nitric oxide modulation and antioxidant activity.

4. Organ Protection

Offers nephroprotective effects in patients with diabetic or hypertensive nephropathy.

May exert antioxidant and anti-inflammatory effects via its sulfhydryl group, offering vascular protection beyond blood pressure control.


 

Benefits

1. Sulfhydryl Group Advantage

Unique among ACE inhibitors for containing a thiol (-SH) group, which may:

Provide additional antioxidant properties

Enhance endothelial protection

Improve nitric oxide bioavailability

2. Long Half-Life

Allows once-daily dosing, improving patient compliance.

3. Well-Tolerated Profile

Fewer side effects compared to older ACE inhibitors; dry cough is less frequent.

Lower incidence of angioedema than bradykinin-potentiating ACE inhibitors.


 

Conclusion

Zofenopril calcium丨CAS 81938-43-4 is a clinically valuable ACE inhibitor used for the treatment of hypertension, heart failure, and post-myocardial infarction care. Its unique thiol group confers additional antioxidant and vascular benefits, setting it apart from other ACE inhibitors. With a favorable efficacy and tolerability profile, it remains a widely prescribed agent in cardiovascular therapeutics.

 

Send Inquiry
Beyond Your Expectation
From Science to Life with LEAPChem
contact us